Coeptis Therapeutics, Inc. (COEP) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.76M | -1.69M | -2.15M | -2.4M | -2.37M | -1.44M | -1.89M | -1.42M | -1.9M | -1.69M | -1.96M | -1.9M |
| Operating CF Margin % | -1545.99% | -195.8% | -906.42% | -1194.3% | -3763.35% | - | - | - | - | - | - | - |
| Operating CF Growth % | 25.67% | -17.5% | -13.72% | -69.05% | -24.38% | 15.19% | 3.36% | 25.5% | -12.94% | -99.89% | -89.54% | -84.12% |
| Net Income | -4.02M | -1.62M | -2.74M | -4.33M | -3.42M | -3.01M | -1.83M | -3.04M | -3M | -3.76M | -6.26M | -3.11M |
| Depreciation & Amortization | 310.51K | 306.01K | 305.76K | 305.53K | 305.3K | 259.98K | 278.23K | 250.21K | 259.34K | 250.31K | 250.31K | 250.31K |
| Stock-Based Compensation | 1.42M | 213.91K | 0 | 191.02K | 597.73K | 299.63K | 96.89K | 611.57K | 96.89K | 0 | 113.3K | 113.3K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.09M | 286.5K |
| Other Non-Cash Items | 535.32K | -694.72K | 861.3K | 2.21M | 372.5K | 1.06M | -300K | 784.85K | 665.02K | 904.14K | 4.85M | 351K |
| Working Capital Changes | 0 | 109.8K | -579.88K | -769.22K | -220.75K | -44.29K | -138.82K | -29.02K | 77.74K | 907.35K | 181.43K | 209.04K |
| Change in Receivables | 0 | 78.69K | -56.04K | -30K | 0 | -82.64K | 0 | 0 | -69.6K | -38.15K | -833 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 122.42K | 101.11K | -241.19K | -91.83K | -149.11K | 135.52K | -146.91K | -84.75K | -53.8K | 937.7K | 86.77K | 152.78K |
| Cash from Investing | 591.52K | 0 | 0 | 0 | 0 | 100K | 0 | 0 | -100K | 0 | 350K | -350K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | 0% | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 85.41K | 0 | 0 | 0 | 0 | 100K | 0 | 0 | -100K | 0 | 350K | -350K |
| Cash from Financing | 704.25K | 2.45M | 5.06M | 125.1K | 6.1M | 731.97K | 1.47M | 1.94M | 1.56M | 1.75M | -224.93K | 3.39M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 771.25K | -63.47K | 0 | 200K | 1.06M | -200K | -725K | 350K |
| Equity Issued (Net) | 0 | 2.45M | 5.06M | 125.1K | 5.33M | 795.44K | 1.52M | 1.69M | 500K | 1.75M | 500.07K | 3.04M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 704.25K | 0 | 0 | 0 | 400 | 0 | -50K | 50K | 0 | 200K | 0 | 0 |
| Net Change in Cash | -463.11K | 765.82K | 2.91M | -2.27M | 3.74M | -604.57K | -417.62K | 525.83K | -439.89K | 57.62K | -1.83M | 1.14M |
| Free Cash Flow | -1.76M | -1.69M | -2.15M | -2.4M | -2.37M | -1.44M | -1.89M | -1.42M | -1.9M | -1.69M | -1.96M | -1.9M |
| FCF Margin % | -1545.99% | -195.8% | -906.42% | -1194.3% | -3763.35% | - | - | - | - | - | - | - |
| FCF Growth % | 25.67% | -17.5% | -13.72% | -69.05% | -24.38% | 15.19% | 3.36% | 25.5% | -12.94% | -99.89% | -89.54% | -84.12% |
| FCF per Share | -0.29 | -0.40 | -0.45 | -0.65 | -0.77 | -0.75 | -0.05 | -0.04 | -0.05 | -0.05 | -0.07 | -0.09 |
| FCF Conversion (FCF/Net Income) | 0.44x | 1.07x | 0.79x | 0.68x | 0.77x | 0.74x | 1.09x | 0.47x | 0.63x | 0.42x | 0.31x | 0.59x |
| Interest Paid | 0 | 0 | 0 | 2.19K | 2.19K | 8.77K | 0 | 0 | 2.19K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |